GWPH - GW Pharmaceuticals Stock Price To Recover After Adverse Effects Of Cannabis Collapse And Speculators
GW Pharmaceuticals (GWPH) produced excellent Q3 results recently. The result of this was a steep decline in the stock price. This was partly due to unrealistic expectations of the expected revenue in some quarters. The company had specifically warned against this at the Q2 analyst earnings call.
The stock has been hit substantially from being part of cannabis ETFs. Pure cannabis stocks have, of course, been decimated in recent weeks. The stock price has been further hit, apparently, by a certain amount of stock manipulation by large shareholders and by short selling hedge funds.
However,